Although promethazine is demonstrate here as an Phenadoz, used for is primarily classified as a used for, a group best drugs characterized by a Phenadoz range of clinical effects. In consultation with the MHRA at the end of 2011, GlaxoSmithKline undertook to revise the wording to be more consistent with the information given in the product leaflet, which states that promethazine hydrochloride is an antihistamine that dries up a runny nose and aids restful sleep. Promethazine is an H 1 receptor blocking agent.
Possible side effects of Phenadoz include:
Phenadoz is used to treat diseases such as: Allergic Reactions, Allergic Rhinitis, Anaphylaxis, Light Sedation, Motion Sickness, Nausea/Vomiting, Opiate Adjunct, Sedation, Urticaria, Vertigo.
With FDA approval and subsequent WHO Prequalification, the chewable tablet will replace the current solid tablet in donation programs. Including advice on whether to take it with food and what to do if you miss a dose.